Program agenda:
- What is the future of the Patent Trial and Appeals Board (PTAB) following the Federal Circuit decision deeming PTAB judges were unconstitutionally appointed?
- How technology transfer offices should evaluate their invention disclosures in light of the USPTO’s updated guidance and procedures.
- What is Congress likely to pass in terms of patent reform and pharma pricing legislation, and how will it affect your licensing and start-up efforts.
- Current status and future prospects for university sovereign immunity in patent challenges.
- Impact of U California’s series of infringement suits against GE and major retailers over its lightbulb patents, and the UC system’s effort in those suits to foster a “national response to the existential threat to university technology transfer”
- Recent Supreme Court and Federal Circuit decisions and their impact on:
- Subject Matter Eligibility
- On-Sale Bar
- Doctrine of Equivalents
- Method of Treatment Claims
- Obviousness
- and much more!
There are already many obstacles to overcome on the path to patenting an invention.
While your TTO struggles to maintain compliance with new legislation and the latest USPTO guidelines and procedures, you also must be prepared to understand and prepare for future changes, evolving legal interpretations, and precedential decisions that can drastically affect how your patent applications are reviewed, approved and challenged. Eligibility guidelines and inter partes reviews are in the hot seat again, and Congress has opened the door to limit pharmaceutical patents in an effort to reduce drug costs.
We’ve teamed up with patent law expert Tyson Benson of the Bejin Beineman law firm in Southfield, Michigan. Join Mr. Benson for this timely session when he will discuss the most critical legal issues now facing your TTO and the latest best practices in light of recent and coming changes to patent law.
